And also for failed executive pay, and failed lobbying, which are much more expensive. In some cases (like Aduhelm) the marketing started before it was shown to

And also for failed executive pay, and failed lobbying, which are much more expensive. In some cases (like Aduhelm) the marketing started before it was shown to have efficacy... so you have to pay for that very expensive failure too. https://www.washingtonpost.com/business/2024/03/08/eli-lilly-alzheimers-donanemab-fda/ https://www.washingtonpost.com/business/2024/03/08/eli-lilly...